Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing
Sign Up to like & getrecommendations! Published in 2018 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2018.00422
Abstract: Parkinson’s disease (PD) involves aggregation of α-synuclein and progressive loss of dopaminergic neurons. Pathogenesis of PD may also be related to one’s genetic background. PD is most common among geriatric population and approximately 1–2% of… read more here.
Keywords: parkinson potential; potential silymarin; silymarin; pharmacology ... See more keywords